Skip to main content

Advertisement

Table 5 Reports of resource utilization in bleeding patients with IMC

From: Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety

Category Count %
Extended LOS 18 100.0%
FFP 12 66.7%
RBC 10 55.6%
Vit K 10 55.6%
Steroids 8 44.4%
PLT 8 44.4%
IVIG 7 38.9%
Plasmapheresis 5 27.8%
Chemotherapy 3 16.7%
  1. LOS – Length of stay; FFP – fresh frozen plasma; Vit K – vitamin K; IVIG – intravenous immune globulin; PLT – platelets; RBC – red blood cells
  2. Interventions among the 18 bleeding patients for whom case reports contained documentation of managing immune-mediated coagulopathy [6, 7, 9, 10, 1517, 20, 23, 26, 27, 30, 31, 33, 34].